According to our results presented here and data published previously by others [16,17,18], WT1 isoforms are expressed in malignant myeloid blasts derived from patients with AML and CML at constant ratios with a predominant expression observed for WT1+/+. Here, WT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.